The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD. (Q46954188)
Jump to navigation
Jump to search
scientific article published in March 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD. |
scientific article published in March 2006 |
Statements
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD (English)
Colin Baigent
Craig Leaper
Dwomoa Adu
Paul Altmann
Jane Armitage
Alex Baxter
Lisa Blackwell
Hugh S Cairns
Sue Carr
Rory Collins
Karen Kourellias
Mary Rogerson
John E Scoble
Graham Warwick
David C Wheeler